申请人:Suven Life Sciences Limited
公开号:US08003670B2
公开(公告)日:2011-08-23
The present invention relates to novel aminoalkoxy arylsulfonamide compounds of the formula (I), their derivatives, their stereoisomers, their pharmaceutically acceptable salts and pharmaceutically acceptable compositions containing them. The present invention also relates to a process for the preparation of above said novel compounds, their derivatives, their stereoisomers, their pharmaceutically acceptable salts and pharmaceutically acceptable compositions containing them. These compounds are useful in the treatment of various disorders that are related to 5-HT6 receptor functions. Specifically, the compounds of this invention are also useful in the treatment of various CNS disorders, hematological disorders, eating disorders, diseases associated with pain, respiratory diseases, genito-urological disorders, cardiovascular diseases and cancer.
本发明涉及公式(I)的新型氨基烷氧基芳基磺酰胺化合物,其衍生物,其立体异构体,其药学上可接受的盐以及含有它们的药学上可接受的组合物。本发明还涉及制备上述新化合物、其衍生物、其立体异构体、其药学上可接受的盐以及含有它们的药学上可接受的组合物的方法。这些化合物在治疗与5-HT6受体功能相关的各种疾病方面是有用的。具体来说,本发明的化合物还在治疗各种中枢神经系统疾病、血液学疾病、进食障碍、与疼痛相关的疾病、呼吸系统疾病、泌尿生殖系统疾病、心血管疾病和癌症方面是有用的。